Management of malignant cutaneous wounds in oncologic patients.
Breast cancer
Malignant wound
Management of wounds
Neoplastic wounds
Oncology
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
16
01
2022
accepted:
30
05
2022
pubmed:
8
6
2022
medline:
20
8
2022
entrez:
7
6
2022
Statut:
ppublish
Résumé
Neoplastic wounds may develop as a result of primary tumor growth in the skin, due to metastasis, or due to skin invasion by tumors emerging from deeper levels. Malignant wounds may present as a crater-like ulcer, or as raised nodules with a cauliflower-like appearance. They are associated with malodor, necrosis, pain, bleeding, and secondary infection. The aim of our study is to better characterize fungating wounds and their management. We retrospectively reviewed the database of the Wound Care Unit of the University of Bologna in order to identify individuals affected by neoplastic wound, between January 2019 and February 2021. We identified 9 females and 2 males with a mean age of 63 years; all were referred by the Oncology Unit. Management differed depending on the characteristics of the patients and the ulcers. Complete healing of the wound, following the parallel complete remission of the lymphoproliferative neoplasia, was observed in one individual. Among the others, one died because of breast cancer, while cutaneous lesions in 2 individuals deteriorated after 1 year of follow-up. Remission/relapse of the ulcer following the treatment course administered for the lymphoma were observed in one patient. Treatment of malignant fungating wounds is challenging. Considering the neoplastic nature of the wounds, complete healing or improvement cannot be expected with the application of classically prescribed dressing for wounds. A mostly palliative treatment, focusing on maintaining the patient's quality of life, is a reasonable choice.
Identifiants
pubmed: 35672478
doi: 10.1007/s00520-022-07194-0
pii: 10.1007/s00520-022-07194-0
pmc: PMC9385755
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7615-7623Informations de copyright
© 2022. The Author(s).
Références
Semin Oncol Nurs. 2006 Aug;22(3):185-93
pubmed: 16893748
Breast Care (Basel). 2011;6(1):21-24
pubmed: 21547022
Dermatol Clin. 2019 Oct;37(4):545-554
pubmed: 31466594
J Wound Care. 2009 Oct;18(10):418-25
pubmed: 19816381
J Wound Care. 2009 Aug;18(8):325-9
pubmed: 19862870
J Wound Care. 2009 Jul;18(7):273-4, 276-8, 280
pubmed: 19827480
Breast Care (Basel). 2017 Dec;12(6):409-414
pubmed: 29456474
J Pain Symptom Manage. 2010 Jun;39(6):1065-76
pubmed: 20538188
Nurs Clin North Am. 2016 Sep;51(3):513-31
pubmed: 27497023
Clin Exp Metastasis. 2021 Feb;38(1):1-10
pubmed: 33180222
Cochrane Database Syst Rev. 2017 Aug 24;8:CD011609
pubmed: 28837757
Clin J Oncol Nurs. 2009 Feb;13(1):113-5
pubmed: 19193558
J Wound Care. 2017 Oct 2;26(10):577-582
pubmed: 28976829
J Wound Care. 2009 Sep;18(9):374-82
pubmed: 19789474
Br J Community Nurs. 2016 Mar;21 Suppl 3:S6-S10
pubmed: 26940736
Br J Nurs. 2005 Jun 9-22;14(11):S4-12
pubmed: 15976610
J Clin Nurs. 2005 Jan;14(1):56-64
pubmed: 15656849
J Wound Ostomy Continence Nurs. 2011 Jan-Feb;38(1):31-7
pubmed: 21287770
J Tissue Viability. 2013 Nov;22(4):122-30
pubmed: 24075006
Palliat Med. 2021 Jan;35(1):179-187
pubmed: 33094681
Cancers (Basel). 2022 Feb 25;14(5):
pubmed: 35267512
Adv Skin Wound Care. 2007 Jun;20(6):312-4
pubmed: 17538255
Br J Nurs. 2017 Jun 22;26(12 Suppl):S6-S14
pubmed: 28640720
J BUON. 2019 May-Jun;24(3):1301-1308
pubmed: 31424694
J Pain Symptom Manage. 2021 Jun;61(6):1278-1286
pubmed: 33096218
J Wound Care. 1999 May;8(5):232-4
pubmed: 10531937
Cochrane Database Syst Rev. 2014 May 15;(5):CD003948
pubmed: 24832784
J Pain Symptom Manage. 2021 Jul;62(1):134-140
pubmed: 33259905
Int Wound J. 2016 Sep;13 Suppl 3:8-14
pubmed: 27547958
Med J Malaysia. 2017 Oct;72(5):316-317
pubmed: 29197891
J Adv Pract Oncol. 2020 Jul;11(5):503-510
pubmed: 32974074